
Ultracare Pharma Private Limited
About Ultracare Pharma Private Limited
Data last updated:
Ultracare Pharma Private Limited is a private limited company based in Jhansi, Uttar Pradesh, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 08 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24304UP2017PTC091161.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Gagan Mishra and Shweta Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 633 De Cruj Compound Masiha Ganj, Jhansi, Uttar Pradesh, India – 284003.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.46 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹1.09 Lakh (net margin 5.1%) and EBITDA of ₹1.16 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years and 46% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ultracare Pharma Private Limited's registered office is in Jhansi, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address633 De Cruj Compound Masiha Ganj, Jhansi, Uttar Pradesh, India – 284003
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Ultracare Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ultracare Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Ultracare Pharma Private Limited, buy the company report.
Financials of Ultracare Pharma Private Limited
FY 2025 filings availableUltracare Pharma Private Limited reported revenue of ₹21.46 Lakh (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 46%. EBITDA rose 224% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.16 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.09 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 5.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ultracare Pharma Private Limited, buy the company report.
Board of directors of Ultracare Pharma Private Limited
Ultracare Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gagan Mishra | Director | 08 Mar 2017 | 9 Years 7 Months | Current |
| Shweta Mishra | Director | 25 Jan 2022 | 4 Years 9 Months | Current |
| Mohit Kumar Bhatnagar | Director | 15 Apr 2025 | 1 Years 6 Months | Current |
Peer comparison
Ultracare Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Akribiz Lifecare Private Limited | ₹21.56 Lakh (FY 2025) | 1199.0% | New Delhi, Delhi, India | |||
| L C Kohli Rehabilitation Clinic Private Limited | ₹21.53 Lakh (FY 2021) | -5.0% | Uttar Pradesh, India | |||
| Intelect Biotech Private Limited | ₹21.5 Lakh (FY 2025) | -18.0% | Farrukhabad, Uttar Pradesh, India | |||
| Jay Vision Care and Ophthalmics Private Limited | ₹21.5 Lakh (FY 2024) | 2458.0% | Mumbai, Maharashtra, India | |||
| Dha Tekhno Private Limited | ₹21.49 Lakh (FY 2025) | -69.0% | Ahmedabad, Gujarat, India | |||
| Ultracare Pharma Private Limitedthis company | ₹21.46 Lakh (FY 2025) | ₹1.09 Lakh | 5.1% | -12.0% | Jhansi, Uttar Pradesh, India | |
| Accumedicare Laboratories Private Limited | ₹21.35 Lakh (FY 2025) | -37.0% | Miyapur, Hyderabad, Telangana, India | |||
| Sat Kartar Health Services Private Limited | ₹21.35 Lakh (FY 2025) | -23.0% | New Delhi, Delhi, India | |||
| I. C. Opticals & Hearing Private Limited | ₹21.35 Lakh (FY 2019) | 62.0% | Gurgaon, Haryana, India | |||
| Santkrapa Healthcare Private Limited | ₹21.34 Lakh (FY 2025) | 48.0% | Agra, Uttar Pradesh, India | |||
| Solene Healthcare Private Limited | ₹21.34 Lakh (FY 2025) | -23.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Ultracare Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ultracare Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ultracare Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ultracare Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ultracare Pharma Private Limited has 7 board changes on record since 2017: 5 appointments and 2 cessations. The latest: Mohit Kumar Bhatnagar was appointed as Director on 15 Apr 2025.
Frequently asked questions
Ultracare Pharma is an active private limited company based in Jhansi, Uttar Pradesh, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 08 March 2017 (9+ years old) and is registered under CIN U24304UP2017PTC091161.
Ultracare Pharma has 3 current directors:
- Gagan Mishra - Director
- Shweta Mishra - Director
- Mohit Kumar Bhatnagar - Director
The latest financial statements of Ultracare Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Ultracare Pharma is U24304UP2017PTC091161. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ultracare Pharma was incorporated on 08 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Ultracare Pharma by revenue are Akribiz Lifecare Private Limited, L C Kohli Rehabilitation Clinic Private Limited, Intelect Biotech Private Limited, Jay Vision Care and Ophthalmics Private Limited, Dha Tekhno Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Mohit Kumar Bhatnagar was appointed as Director on 15 Apr 2025. Pradeep Kumar Mishra ceased to be Director on 27 Jan 2022. Shweta Mishra was appointed as Director on 25 Jan 2022. Ultracare Pharma has 7 board changes on record in total.
The registered office of Ultracare Pharma is at 633 De Cruj Compound Masiha Ganj, Jhansi, Uttar Pradesh, India – 284003.
Ultracare Pharma operates in the food and beverages industry, in the manufacturing segment.
The compliance status of Ultracare Pharma is compliant as of 08 September 2026. The company is actively filing with the Registrar of Companies.
Ultracare Pharma can be reached at its registered office: 633 De Cruj Compound Masiha Ganj, Jhansi, Uttar Pradesh, India – 284003.

